On the applications of Fisher's least significant difference (LSD) procedure in three-arm clinical trials with survival endpoints

Drug Information Journal

Volumn 42, Issue 1, 2008, Pages 81-91

  Liu, Shifang ^a   Tu, Dongsheng ^b  

^a Everest Clinical Research Services   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Multiple adjustment; Pairwise comparison; Power; Sample size; Survival; Three arms

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FISHER LEAST SIGNIFICANT DIFFERENCE; HUMAN; INTERMETHOD COMPARISON; MONTE CARLO METHOD; PRIORITY JOURNAL; SAMPLE SIZE; SOLID TUMOR; STATISTICAL ANALYSIS; SURVIVAL;

EID: 51049110700     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150804200112     Document Type: Article

References (12)

1. Meier U. A note on the power of Fisher's least significant difference procedure. Pharm Stat. 2006; 5:253-263.
2. Makuch RW, Simon RM. Sample size requirements for comparing time-to-failure among k treatment groups. J Chron Dis. 1982;35:861-867.
3. Liu PY, Dahlberg S. Design and analysis of multi-arm clinical trials with survival endpoints. Control Clin Trials. 1995;16:119-130.
4. Ahnn S, Anderson SJ. Sample size determination for comparing more than two survival distributions. Stat Med. 1995;14:2273-2282.
5. Ahnn S, Anderson SJ. Sample size determination in complex clinical trials comparing more than two groups for survival endpoints. Stat Med. 1998;17:2525-2534.
6. Halabi S, Singh B. Sample size determination for comparing several survival curves with unequal allocations. Stat Med. 2004;23:1793-1815.
7. Barthel FMS, Babiker A, Royston P, Parmar MKB. Evaluation of sample size and power for multi-arm survival trials allowing for non-uniform accrual. non-proportional hazards, loss to follow-up and cross-over. Stat Med. 2006;25:2521-2542.
8. Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y. Multiple Comparisons and Multiple Tests Using SAS®. Cary, NC: SAS Institute Inc.; 1999.
9. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988; 75:800-802.
10. Rubinstein LV, Gail MH, Santner TJ. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chron Dis. 1981;34:469-479.
11. Casella G, Berger RL. Statistical Inference. Belmont, CA: Wadsworth Inc.; 1990.
12. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chron Dis. 1974;27:15-29.